Evolution of drug resistance in multiple distinct lineages of H5N1 avian influenza
- 31 March 2009
- journal article
- Published by Elsevier BV in Infection, Genetics and Evolution
- Vol. 9 (2), 169-178
- https://doi.org/10.1016/j.meegid.2008.10.006
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutantsNature, 2008
- The emergence of adamantane resistance in influenza A(H1) viruses in Australia and regionally in 2006Antiviral Research, 2007
- Increased adamantane resistance in influenza A(H3) viruses in Australia and neighbouring countries in 2005Antiviral Research, 2007
- Distribution of Amantadine‐Resistant H5N1 Avian Influenza Variants in AsiaThe Journal of Infectious Diseases, 2006
- Adamantane Resistance Among Influenza A Viruses Isolated Early During the 2005-2006 Influenza Season in the United StatesJAMA, 2006
- Establishment of multiple sublineages of H5N1 influenza virus in Asia: Implications for pandemic controlProceedings of the National Academy of Sciences of the United States of America, 2006
- Oseltamivir Resistance during Treatment of Influenza A (H5N1) InfectionNew England Journal of Medicine, 2005
- Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concernThe Lancet, 2005
- Flu pills for a pandemic threatDrug Discovery Today, 2005
- MUSCLE: multiple sequence alignment with high accuracy and high throughputNucleic Acids Research, 2004